Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : email@example.com
|Molecular Profile||Indication/Tumor Type||Response Type||Therapy Name||Approval Status||Evidence Type||Efficacy Evidence||References|
|Unknown unknown||triple-receptor negative breast cancer||not applicable||AMG 900 + Ixabepilone||Preclinical - Cell line xenograft||Actionable||In a preclinical study, treatment with the combination of AMG 900 and Ixempra (ixabepilone) resulted in tumor regression in triple-negative breast cancer cell line xenograft models (PMID: 23990115).||23990115|